Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/18/2025
WuXi Biologics Completes 15,000L PPQ at Hangzhou Site
4/17/2025
WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount
2/18/2025
WuXi XDC in Strategic Transformation through Ownership Shift and Capit...
1/28/2025
China's Evolving Role in Pharma Spurs Regional Realignments, Boosts In...
1/20/2025
JOINN Biologics Acquires Lonza's Large Molecule CDMO Facility in Guang...
1/12/2025
WuXi Biologics Announces Agreement with Candid Therapeutics on Trispec...
1/6/2025
WuXi Bio Divests Irish Vaccine Facility to Merck Amid Potential U.S. R...
12/24/2024
WuXi Biologics to Divest Advanced Therapies Unit Amid U.S. Restriction...
12/10/2024
China Biopharma CDMOs Win Reprieve as Biosecure Act Omitted from US De...
11/18/2024
WuXi AppTec Opens New R&D Center in Changzhou
11/18/2024
C Ray Thera Secures Over $100M to Advance Radiopharma Innovations
11/4/2024
BIOSECURE Act May Shift Biopharma Manufacturing from China to India, S...
10/28/2024
China Expands Contract Manufacturing for Biopharmaceuticals in New Pil...
10/3/2024
WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT
9/23/2024
Is Biotech the Next Battleground in US-China Decoupling? (SCMP)
9/20/2024
Another Twist in the Biosecure Drama Leaves Bill's Fate Uncertain
9/20/2024
Why 'Big Pharma' Will be the Next China Trade War Battleground (Invest...
9/17/2024
Biopharma Prepares to Pivot from China as Biosecure Act Advances (Phar...
9/9/2024
House Passes BIOSECURE Act, Targeting Chinese Biotech Companies
9/4/2024
Acceleration in China+1 trend in Pharmaceuticals Sector! (HDFC)
8/6/2024
Asymchem Inaugurates New Site in Sandwich, UK
8/1/2024
WuXi Biologics Granted EMA Approval for Five Chinese Facilities
7/29/2024
BeiGene CEO Mulls Biologics Partnerships for New Innovation Center in ...
7/18/2024
India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...
7/10/2024
House Speaker Mike Johnson Pledges Vote for BIOSECURE as China-targeti...
6/27/2024
Industry Braces for Biosecure Act Impact (C&EN)
5/31/2024
Building Resilient Supply Chains in the Face of Tightening Chinese Ant...
5/24/2024
WuXi AppTec Breaks Ground on New Site in Singapore
5/23/2024
Asymchem Takes Over Former Pfizer UK Site to Expand Global Footprint
5/10/2024
House's Updated Biosecurity Bill Sets 2032 Decoupling Deadline for Ind...
Page:
1
/
17
Total number of articles:
490
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit